ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)

	ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)
	Cheng, Y.2; Wang, J.3; Cang, S.4; Cao, L.5; Chen, E.6; Dong, X.7; Fan, Y.8; Gao, B.9; Guo, Q.10; Huang, D.11
刊名	JOURNAL OF THORACIC ONCOLOGY
	2021-04-01
卷号	16
ISSN号	1556-0864
资助项目	AstraZeneca
WOS研究方向	Oncology ; Respiratory System
语种	英语
出版者	ELSEVIER SCIENCE INC
WOS记录号	WOS:000634855900061
资助机构	AstraZeneca
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/121059]
专题	中国科学院合肥物质科学研究院
作者单位	1.Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China 2.Jilin Prov Canc Hosp, Changchun, Jilin, Peoples R China 3.Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China 4.Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China 5.Univ Sci & Technol China, USTC, Affiliated Hosp 1, Hefei, Anhui, Peoples R China 6.Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China 7.Wuhan Union Hosp, Wuhan, Hubei, Peoples R China 8.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Zhejiang, Peoples R China 9.Ruijin Hosp, Shanghai, Peoples R China 10.Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
推荐引用方式 GB/T 7714	Cheng, Y.,Wang, J.,Cang, S.,et al. ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)[J]. JOURNAL OF THORACIC ONCOLOGY,2021,16.
APA	Cheng, Y..,Wang, J..,Cang, S..,Cao, L..,Chen, E..,...&Gao, M..(2021).ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC).JOURNAL OF THORACIC ONCOLOGY,16.
MLA	Cheng, Y.,et al."ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)".JOURNAL OF THORACIC ONCOLOGY 16(2021).